Physician

Kerry E Chamberlain, DO

According to 2025 Medicare claims, Kerry Chamberlain, DO (NPI: 1073502233) practices hematology/oncology in the St. Petersburg-Clearwater-Largo, FL market, with the plurality of this provider's patient population coming from Pinellas, FL. This provider's primary affiliated billing organization is FLORIDA CANCER SPECIALISTS & RESEARCH INSTITUTE, LLC (NPI: 1760590962; TIN: 65-0825133) and primary practice location at 33770-2542.

Chamberlain's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 683 traditional Medicare patients, billed 140,568 HCPCS/CPT codes, and received $2,004,646 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 840 prescription claims across 171 beneficiaries totaling $2,363,403 in drug costs, led by Revlimid (Lenalidomide). DME data shows 22 claims. Open Payments data shows 85 records totaling $1,795. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has declined steadily, from $2,623,332 to $2,004,646. In contrast, Part D prescription costs have moved from a lower plateau to a higher plateau, from $657,443 to $2,363,403. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$1.6M$3.3M2015 Medicare payment: $2,623,332 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $2,773,446 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $3,266,249 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $3,166,650 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $2,866,128 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $2,642,725 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $2,416,161 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $2,067,547 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $2,215,988 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $2,004,646 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20151,019237,964$2,623,332
20161,099233,151$2,773,446
20171,954276,584$3,266,249
20181,115273,693$3,166,650
20191,110244,840$2,866,128
2020897213,661$2,642,725
2021714193,891$2,416,161
2022674169,334$2,067,547
2023706195,200$2,215,988
2024683140,568$2,004,646

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$1.2M$2.4M2015 Drug cost: $657,443 (USD; Tot_Drug_Cst)2016 Drug cost: $946,047 (USD; Tot_Drug_Cst)2017 Drug cost: $722,163 (USD; Tot_Drug_Cst)2018 Drug cost: $798,066 (USD; Tot_Drug_Cst)2019 Drug cost: $1,052,694 (USD; Tot_Drug_Cst)2020 Drug cost: $1,292,299 (USD; Tot_Drug_Cst)2021 Drug cost: $1,023,326 (USD; Tot_Drug_Cst)2022 Drug cost: $1,308,692 (USD; Tot_Drug_Cst)2023 Drug cost: $1,820,870 (USD; Tot_Drug_Cst)2024 Drug cost: $2,363,403 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015145695$657,443
2016148775$946,047
2017167800$722,163
2018169769$798,066
2019169785$1,052,694
2020172747$1,292,299
2021154639$1,023,326
2022163735$1,308,692
2023167811$1,820,870
2024171840$2,363,403

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

DME Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: DME_Suplr_Mdcr_Pymt_Amt. Source: Medicare DME, Devices & Supplies by Referring Provider.0$5.6K$11K2015 Medicare payment: $653 (USD; DME_Suplr_Mdcr_Pymt_Amt)2016 Medicare payment: $11,215 (USD; DME_Suplr_Mdcr_Pymt_Amt)2019 Medicare payment: $893 (USD; DME_Suplr_Mdcr_Pymt_Amt)2024 Medicare payment: $1,118 (USD; DME_Suplr_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClaimsPayment
2015N/R24$653
2016N/R31$11,215
2017N/RN/RN/R
2018N/RN/RN/R
2019N/R22$893
2020N/RN/RN/R
2021N/RN/RN/R
2022N/RN/RN/R
2023N/RN/RN/R
2024N/R22$1,118

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more166445$95
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more290533$64
36415Insertion of needle into vein for collection of blood sample4971,572$9
85025Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count4601,575$8
85046Red blood count automated, with additional calculations163232$5

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
RevlimidLenalidomide31868$575,463
PomalystPomalidomide20560$461,084
JakafiRuxolitinib Phosphate21625$264,465
TagrissoOsimertinib Mesylate12360$198,856
BrukinsaZanubrutinib12360$177,176

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS CodeHCPCS DescriptionSupplier Rental IndicatorTotal Supplier BeneficiariesTotal Supplier ClaimsTotal Medicare Payment Amount
J8700Temozolomide, oral, 5 mgNN/R11$767
Q0512Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for a subsequent prescription in a 30-day periodNN/R11$351

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.85$1,795Celgene Corporation
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Kerry E. Chamberlain, DO?

Tedicare shows public-source Medicare data for Kerry E. Chamberlain, DO (NPI 1073502233), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Kerry E. Chamberlain, DO have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Kerry E. Chamberlain, DO?

Kerry E. Chamberlain, DO is linked to FLORIDA CANCER SPECIALISTS & RESEARCH INSTITUTE, LLC (billing NPI 1760590962) in the available physician profile data.

Does Kerry E. Chamberlain, DO have Open Payments data?

Kerry E. Chamberlain, DO has 85 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.